|Last Updated: May 25, 2019 @ 9:13 am|
|Stability:||Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: Unacceptable; Incubated: Unacceptable|
|Interpretive Data:||Please see report for interpretive data.|
The Aptima HPV Assay is an in vitro nuclei acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The high-risk types detected by the assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The analytical performance characteristics of this assay, when used to test Surepath specimens, have been determined by Medical Lab Associates.The use of this test is indicated for screening women 21 years and older with ASCUS cervical cytology results. In woman 30 years and older, the assay can be used adjunctively with cervical cytology to guide patient management.